These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 6605355

  • 1. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ, Wellen JJ, Rijken JC, Stoelinga GB, Benraad TJ.
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
    [Abstract] [Full Text] [Related]

  • 2. Correlation between androstenedione and 17-hydroxyprogesterone levels in the saliva and plasma of patients with congenital adrenal hyperplasia.
    Juniarto AZ, Goossens K, Setyawati BA, Drop SL, de Jong FH, Faradz SM.
    Singapore Med J; 2011 Nov; 52(11):810-3. PubMed ID: 22173250
    [Abstract] [Full Text] [Related]

  • 3. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J, Gueux B, Gourmelen M, Kuttenn F, Vexiau P, Couillin P, Pham-Huu-Trung MT, Villette JM, Raux-Demay MC, Galons H.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [Abstract] [Full Text] [Related]

  • 4. [Salivary 17-hydroxyprogesterone concentration in monitoring of the treatment of congenital adrenal hyperplasia].
    Arisaka O, Shimura N, Nakayama Y, Arisaka M, Yabuta K.
    Dtsch Med Wochenschr; 1988 Dec 09; 113(49):1913-5. PubMed ID: 3197614
    [Abstract] [Full Text] [Related]

  • 5. Enzyme immunoassay of 17-hydroxyprogesterone in plasma, microfilter paper blood and saliva of newborns, children and patients with congenital adrenal hyperplasia.
    Hubl W, Fehér T, Rohde W, Dörner G, Taubert H, Freymann E.
    Endokrinologie; 1982 Jun 09; 79(2):165-72. PubMed ID: 6751805
    [Abstract] [Full Text] [Related]

  • 6. Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia.
    de Groot MJ, Pijnenburg-Kleizen KJ, Thomas CM, Sweep FC, Stikkelbroeck NM, Otten BJ, Claahsen-van der Grinten HL.
    Clin Chem Lab Med; 2015 Feb 09; 53(3):461-8. PubMed ID: 25283138
    [Abstract] [Full Text] [Related]

  • 7. 17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.
    von Schnakenburg K, Bidlingmaier F, Knorr D.
    Eur J Pediatr; 1980 May 09; 133(3):259-67. PubMed ID: 7389739
    [Abstract] [Full Text] [Related]

  • 8. [Radioimmunoassay of salivary l7 alpha-hydroxyprogesterone. Values obtained in healthy subjects and in patients treated for congenital hyperplasia of the adrenal glands].
    Guechot J, Fiet J, Gourmelen M, Pham-Huu-Trung MT, Raux-Eurin MC, Brerault JL, Gueux B, Villette JM.
    Ann Biol Clin (Paris); 1985 May 09; 43(4):333-7. PubMed ID: 4091295
    [Abstract] [Full Text] [Related]

  • 9. Development of a highly sensitive nonisotopic immunoassay for the determination of salivary 17-hydroxyprogesterone: reference ranges throughout childhood and adolescence.
    Dressendorfer RA, Strasburger CJ, Bidlingmaier F, Klug I, Kistner A, Siebler T, Kiess W.
    Pediatr Res; 1998 Nov 09; 44(5):650-5. PubMed ID: 9803445
    [Abstract] [Full Text] [Related]

  • 10. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Gröschl M, Rauh M, Dörr HG.
    J Clin Endocrinol Metab; 2002 Mar 09; 87(3):1200-4. PubMed ID: 11889188
    [Abstract] [Full Text] [Related]

  • 11. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency.
    Zerah M, Pang SY, New MI.
    J Clin Endocrinol Metab; 1987 Aug 09; 65(2):227-32. PubMed ID: 3496350
    [Abstract] [Full Text] [Related]

  • 12. Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Pang S, Pollack MS, Loo M, Green O, Nussbaum R, Clayton G, Dupont B, New MI.
    J Clin Endocrinol Metab; 1985 Jul 09; 61(1):89-97. PubMed ID: 3873469
    [Abstract] [Full Text] [Related]

  • 13. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J, Lisá L, Dvorák P, Hampl R, Stárka L.
    Cesk Pediatr; 1990 Jun 09; 45(6):353-6. PubMed ID: 2289256
    [Abstract] [Full Text] [Related]

  • 14. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
    Feuillan P, Pang S, Schürmeyer T, Avgerinos PC, Chrousos GP.
    J Clin Endocrinol Metab; 1988 Jul 09; 67(1):154-60. PubMed ID: 2837498
    [Abstract] [Full Text] [Related]

  • 15. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
    Noppe G, de Rijke YB, Koper JW, van Rossum EF, van den Akker EL.
    Clin Endocrinol (Oxf); 2016 Oct 09; 85(4):522-7. PubMed ID: 27061431
    [Abstract] [Full Text] [Related]

  • 16. Studies on the diurnal variations of 17-hydroxyprogesterone in saliva by enzyme immunoassay in patients with congenital adrenal hyperplasia.
    Hoepffner W, Hubl W.
    Exp Clin Endocrinol; 1986 Jul 09; 87(2):189-94. PubMed ID: 3530788
    [Abstract] [Full Text] [Related]

  • 17. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW, Ma HM, Su Z, Du ML, Li YH, Chen HS, Chen QL.
    Zhonghua Er Ke Za Zhi; 2012 Apr 09; 50(4):301-7. PubMed ID: 22801236
    [Abstract] [Full Text] [Related]

  • 18. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L, Virdis R, Vottero A, Cappa M, Street ME, Zampolli M, Ibañez L, Bernasconi S.
    J Clin Endocrinol Metab; 1996 Feb 09; 81(2):601-6. PubMed ID: 8636275
    [Abstract] [Full Text] [Related]

  • 19. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
    Fiet J, Gueux B, Raux-DeMay MC, Kuttenn F, Vexiau P, Brerault JL, Couillin P, Galons H, Villette JM, Julien R.
    J Clin Endocrinol Metab; 1989 Mar 09; 68(3):542-7. PubMed ID: 2537337
    [Abstract] [Full Text] [Related]

  • 20. Diurnal salivary androstenedione and 17-hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia.
    Adriaansen BPH, Kamphuis JS, Schröder MAM, Olthaar AJ, Bock C, Brandt A, Stikkelbroeck NMML, Lentjes EGWM, Span PN, Sweep FCGJ, Claahsen-van der Grinten HL, van Herwaarden AE.
    Clin Endocrinol (Oxf); 2022 Jul 09; 97(1):36-42. PubMed ID: 35150157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.